Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Goldstein, Ellie J C
Tillotson, Glenn
and
Redell, Mark
2020.
Antimicrobial Management of Respiratory Infections in Severe Acute Respiratory Syndrome Coronavirus 2 Patients: Clinical and Antimicrobial Stewardship Programs Conundrums.
Open Forum Infectious Diseases,
Vol. 7,
Issue. 11,
Gajdács, Márió
Ábrók, Marianna
Lázár, Andrea
and
Burián, Katalin
2020.
Differential epidemiology and antibiotic resistance of lactose-fermenting and non-fermenting Escherichia coli: Is it just a matter of taste?.
Biologia Futura,
Vol. 71,
Issue. 1-2,
p.
175.
Bork, Jacqueline T.
Werzen, Alissa
Davé, Rohini
Morgan, Daniel J.
Talwani, Rohit
and
Decker, Brooke
2020.
Improving Antimicrobial Use in Adult Outpatient Clinics: the New Frontier for Antimicrobial Stewardship Programs.
Current Infectious Disease Reports,
Vol. 22,
Issue. 5,
Shealy, Stephanie C.
Brigmon, Matthew M.
Justo, Julie Ann
Bookstaver, P. Brandon
Kohn, Joseph
and
Al-Hasan, Majdi N.
2020.
Impact of Reappraisal of Fluoroquinolone Minimum Inhibitory Concentration Susceptibility Breakpoints in Gram-Negative Bloodstream Isolates.
Antibiotics,
Vol. 9,
Issue. 4,
p.
189.
Gandhi, Aditya R
Rao, Sowmya R
Chen, Lin H
Nelson, Michael D
Ryan, Edward T
LaRocque, Regina C
and
Hyle, Emily P
2020.
Prescribing Patterns of Antibiotics for the Self-Treatment of Travelers’ Diarrhea in Global TravEpiNet, 2009–2018.
Open Forum Infectious Diseases,
Vol. 7,
Issue. 10,
Hamrick, Jodie C.
Docquier, Jean-Denis
Uehara, Tsuyoshi
Myers, Cullen L.
Six, David A.
Chatwin, Cassandra L.
John, Kaitlyn J.
Vernacchio, Salvador F.
Cusick, Susan M.
Trout, Robert E. L.
Pozzi, Cecilia
De Luca, Filomena
Benvenuti, Manuela
Mangani, Stefano
Liu, Bin
Jackson, Randy W.
Moeck, Greg
Xerri, Luigi
Burns, Christopher J.
Pevear, Daniel C.
and
Daigle, Denis M.
2020.
VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in
Enterobacterales
and Pseudomonas aeruginosa
.
Antimicrobial Agents and Chemotherapy,
Vol. 64,
Issue. 3,
Winders, Hana R.
Royer, Julie
Younas, Mariam
Justo, Julie Ann
Bookstaver, P. Brandon
Weissman, Sharon B.
Bell, Linda
Waites, Katie S.
Plante, John
and
Al-Hasan, Majdi N.
2020.
Temporal trends in ambulatory antibiotic prescription rates in South Carolina: Impact of age, gender, and resident location.
Infection Control & Hospital Epidemiology,
Vol. 41,
Issue. 8,
p.
879.
Freeman, Maya Z.
Cannizzaro, Deanna N.
Naughton, Lydia F.
and
Bove, Cecilia
2021.
Fluoroquinolones-Associated Disability: It Is Not All in Your Head.
NeuroSci,
Vol. 2,
Issue. 3,
p.
235.
Moehring, Rebekah W
Yarrington, Michael E
Davis, Angelina E
Dyer, April P
Johnson, Melissa D
Jones, Travis M
Spires, S Shaefer
Anderson, Deverick J
Sexton, Daniel J
and
Dodds Ashley, Elizabeth S
2021.
Effects of a Collaborative, Community Hospital Network for Antimicrobial Stewardship Program Implementation.
Clinical Infectious Diseases,
Vol. 73,
Issue. 9,
p.
1656.
Tran, Phuong T.
Antonelli, Patrick J.
Hincapie-Castillo, Juan M.
and
Winterstein, Almut G.
2021.
Association of US Food and Drug Administration Removal of Indications for Use of Oral Quinolones With Prescribing Trends.
JAMA Internal Medicine,
Vol. 181,
Issue. 6,
p.
808.
Sankar, Ashwini
Swanson, Kristi M.
Zhou, Jiani
Jena, Anupam Bapu
Ross, Joseph S.
Shah, Nilay D.
and
Karaca-Mandic, Pinar
2021.
Association of Fluoroquinolone Prescribing Rates With Black Box Warnings from the US Food and Drug Administration.
JAMA Network Open,
Vol. 4,
Issue. 12,
p.
e2136662.
McNeil, Benjamin D.
2021.
MRGPRX2 and Adverse Drug Reactions.
Frontiers in Immunology,
Vol. 12,
Issue. ,
Buehrle, Deanna J.
Wagener, Marilyn M.
and
Clancy, Cornelius J.
2021.
Outpatient Fluoroquinolone Prescription Fills in the United States, 2014 to 2020: Assessing the Impact of Food and Drug Administration Safety Warnings.
Antimicrobial Agents and Chemotherapy,
Vol. 65,
Issue. 7,
Alrawashdeh, Mohammad
Rhee, Chanu
Hsu, Heather
Wang, Rui
Horan, Kelly
and
Lee, Grace M.
2021.
Assessment of Federal Value-Based Incentive Programs and In-Hospital Clostridioides difficile Infection Rates.
JAMA Network Open,
Vol. 4,
Issue. 10,
p.
e2132114.
Li, Catherine
Mercuro, Nicholas J.
Chapin, Ryan W.
Gold, Howard S.
and
McCoy, Christopher
2021.
Fluoroquinolone Prescribing for Diabetic Foot Infections following an FDA Drug Safety Communication for Aortic Aneurysm Risk.
Antimicrobial Agents and Chemotherapy,
Vol. 65,
Issue. 9,
Umarje, Siddhi Pramod
Alexander, Caleb G
and
Cohen, Andrew J
2021.
Ambulatory Fluoroquinolone Use in the United States, 2015–2019.
Open Forum Infectious Diseases,
Vol. 8,
Issue. 12,
Cannizzaro, Deanna N.
Naughton, Lydia F.
Freeman, Maya Z.
Martin, Linda
Bennett, Charles L.
and
Bove, Cecilia
2021.
A New Criterion for Fluoroquinolone-Associated Disability Diagnosis: Functional Gastrointestinal Disorders.
Medicina,
Vol. 57,
Issue. 12,
p.
1371.
Smoke, Steven M.
Plotkin, Slava
Patel, Neeki
and
Hilden, Patrick
2022.
Save the Quinolones! Impact of a Non-Restrictive Fluoroquinolone Reduction Initiative on Antibiotic Use and Resistance at an Urban Teaching Hospital.
Journal of Pharmacy Practice,
Vol. 35,
Issue. 5,
p.
707.
Sparkes, Dominic
and
Enoch, David A
2022.
Comprehensive Pharmacology.
p.
240.
Wu, Yue
Xiao, Wenzhong
Tong, Weida
Borlak, Jürgen
and
Chen, Minjun
2022.
A systematic comparison of hepatobiliary adverse drug reactions in FDA and EMA drug labeling reveals discrepancies.
Drug Discovery Today,
Vol. 27,
Issue. 1,
p.
337.